Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK

Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

(2017) Luigina Romani et al.   NATURE MEDICINE

New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity

(2016) Walter Mandaliti et al.   AMINO ACIDS

Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier

(2016) Walter Mandaliti et al.   BIOCHEMISTRY

Binding of synthetic LKEKK peptide to human T-lymphocytes

(2016) E. V. Navolotskaya et al.   BIOCHEMISTRY-MOSCOW

Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases

(2016) F. Pica et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Historical review on thymosin α1 in oncology: preclinical and clinical experiences

(2015) Enrico Garaci et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Thymosin α1 inserts N terminus into model membranes assuming a helical conformation

(2015) Ridvan Nepravishta et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR)

(2015) Kenneth Virgel N. Esguerra et al.   Integrative Biology

Hyaluronan, Inflammation, and Breast Cancer Progression

(2015) Kathryn L. Schwertfeger et al.   Frontiers in Immunology

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer

(2015) Suniti Misra et al.   Frontiers in Immunology

Mechanisms of apoptotic phosphatidylserine exposure

(2013) Guillermo Mariño et al.   CELL RESEARCH

Thymosin α1 Activates Complement Receptor-Mediated Phagocytosis in Human Monocyte-Derived Macrophages

(2013) Annalucia Serafino et al.   Journal of Innate Immunity

Using chemical shift perturbation to characterise ligand binding

(2013) Mike P. Williamson   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

A RHAMM Mimetic Peptide Blocks Hyaluronan Signaling and Reduces Inflammation and Fibrogenesis in Excisional Skin Wounds

(2012) Cornelia Tolg et al.   AMERICAN JOURNAL OF PATHOLOGY

Thymosin α1 and cancer: action on immune effector and tumor target cells

(2012) Enrico Garaci et al.   Annals of the New York Academy of Sciences

Jack of all trades: thymosin α1 and its pleiotropy

(2012) Luigina Romani et al.   Annals of the New York Academy of Sciences

NMR structure of human thymosin alpha-1

(2011) Miguel-Angel Elizondo-Riojas et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

RHAMM and CD44 peptides-analytic tools and potential drugs

(2011) Eva et al.   Frontiers in Bioscience-Landmark

Understanding the Dual Nature of CD44 in Breast Cancer Progression

(2011) J. M. V. Louderbough et al.   MOLECULAR CANCER RESEARCH

Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega

(2011) F. Sievers et al.   Molecular Systems Biology

Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study

(2011) G. Carraro et al.   VACCINE

Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor

(2010) Shibnath Ghatak et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

(2010) Michele Maio et al.   JOURNAL OF CLINICAL ONCOLOGY

From lab to bedside: emerging clinical applications of thymosin α1

(2009) Allan L Goldstein et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Activation of the innate immune system by the endogenous ligand hyaluronan

(2008) Anushree C Shirali et al.   Current Opinion in Organ Transplantation